Microbiology laboratory, Xi'an Centre for Disease Control and Prevention, Xi'an, Shaanxi Province, China.
Department of Obstetrics and Gynaecology, Pingchuan District People's Hospital, Baiyin, Gansu Province, China.
J Int Med Res. 2022 Feb;50(2):3000605221078782. doi: 10.1177/03000605221078782.
To analyse macrolide resistance and molecular characteristics of clinical isolates from western China, and to explore the relationship between macrolide-resistance and genotypes.
Susceptibilities of clinical isolates to erythromycin, azithromycin and clarithromycin were determined by epsilometer test (E-test). Isolated strains were sequenced to ascertain the presence of the 23S rRNA gene A2047G mutation. Strains were typed using multilocus antigen sequence typing, multilocus variable-number tandem-repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE).
Of 58 strains isolated in this study, 46 were macrolide-resistant and 12 were macrolide sensitive. All macrolide-resistant strains carried the A2047G mutation and were the //// genotype; the MLVA types were MT195 (19/58), MT55 (13/58) and MT104 (14/58), and the PFGE profiles were classified into BpSR23 (17/58) and BpFINR9 (29/58) types. None of the macrolide-sensitive strains carried the A2047G mutation; genotypes were ( or )////, and all were MT27. PFGE profiles differed from the macrolide-resistant strains.
clinical isolates from western China were severely resistant to macrolides. Genotypes differed between macrolide-resistant and macrolide-sensitive strains, and there may be a correlation between acquisition of macrolide resistance and changes in specific molecular types.
分析中国西部临床分离株的大环内酯类耐药性和分子特征,并探讨大环内酯类耐药性与基因型之间的关系。
采用 E 试验法测定临床分离株对红霉素、阿奇霉素和克拉霉素的药敏性。对分离株进行测序以确定 23S rRNA 基因 A2047G 突变的存在。采用多位点抗原序列分型、多位点可变数串联重复分析(MLVA)和脉冲场凝胶电泳(PFGE)对菌株进行分型。
本研究共分离出 58 株菌株,其中 46 株为大环内酯类耐药株,12 株为大环内酯类敏感株。所有大环内酯类耐药株均携带 A2047G 突变,均为 //// 基因型;MLVA 型为 MT195(19/58)、MT55(13/58)和 MT104(14/58),PFGE 图谱分为 BpSR23(17/58)和 BpFINR9(29/58)型。所有大环内酯类敏感株均未携带 A2047G 突变;基因型为(或)////,均为 MT27。PFGE 图谱与大环内酯类耐药株不同。
来自中国西部的临床分离株对大环内酯类药物高度耐药。大环内酯类耐药株和敏感株的基因型不同,大环内酯类耐药的获得与特定分子类型的变化之间可能存在相关性。